Tempus AI(TEM.US)

Last Updated 19:00:00 ET
longbridge loading

How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here

Barchart Option·
US
TEM
+4.38%
Barchart Option·
US
TEM
+4.38%

Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts

benzinga_article·
US
TEM
+4.38%
US
BMY
+1.74%
US
PBE
+0.11%
benzinga_article·
US
TEM
+4.38%
US
BMY
+1.74%
US
PBE
+0.11%

Cathie Wood, Ross Gerber Snap Up The Same 10 Stocks — Here's The Unlikely Portfolio Crossover

benzinga_article·
US
LLY
+3.37%
US
NVDA
-0.77%
US
GOOGL
-2.34%
benzinga_article·
US
LLY
+3.37%
US
NVDA
-0.77%
US
GOOGL
-2.34%

Tempus AI Prices $460 Million 0% Convertible Notes Due 2032, Retires Senior Credit Facility

TradingView·
US
TEM
+4.38%
TradingView·
US
TEM
+4.38%

If AI Reshapes Healthcare, These Three Stocks Could Lead

Simplywall·
US
MDT
+1.63%
US
PFE
+1.30%
US
TEM
+4.38%
Simplywall·
US
MDT
+1.63%
US
PFE
+1.30%
US
TEM
+4.38%

Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB

MSN·
US
RKLB
-2.94%
US
CRWV
-3.82%
US
NTLA
-5.91%
MSN·
US
RKLB
-2.94%
US
CRWV
-3.82%
US
NTLA
-5.91%

Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

fidelity·
US
TEM
+4.38%
US
PBE
+0.11%
US
IBB
+0.10%
fidelity·
US
TEM
+4.38%
US
PBE
+0.11%
US
IBB
+0.10%

BTIG Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)

Tip Ranks·
US
TEM
+4.38%
US
BIB
+0.05%
US
BBH
+0.68%
Tip Ranks·
US
TEM
+4.38%
US
BIB
+0.05%
US
BBH
+0.68%

3 Stocks Poised to Disrupt the Healthcare Market by 2030

nasdaq·
US
AXSM
-0.32%
US
RXRX
-1.38%
US
TEM
+4.38%
nasdaq·
US
AXSM
-0.32%
US
RXRX
-1.38%
US
TEM
+4.38%
© 2026 Longbridge｜Disclaimer